Jefferies Downgrades Salix Pharmaceuticals (SLXP) to Hold; VRX Raised Bid Appears Final
Tweet Send to a Friend
Jefferies downgraded Salix Pharmaceuticals (NASDAQ: SLXP) from Buy to Hold with a price target of $173.00 (from $149.00), saying the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
